SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION

Amiodarone is one of the basic antiarrhytmic drugs for atrial fibrillation treatment. However application of amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome can induce ventricular fibrillation. Amiodarone usage in these patients should be accompanied by readiness f...

Full description

Bibliographic Details
Main Authors: D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
amiodarone
atrial fibrillation
wolff-parkinson-white syndrome
ventricular fibrillation
Online Access:https://www.rpcardio.com/jour/article/view/879

Internet

https://www.rpcardio.com/jour/article/view/879

Similar Items